Autobacs Seven Co Ltd (JP:9832)
:9832
Want to see JP:9832 full AI Analyst Report?
9832 Stock Chart & Stats
¥1571.00
-¥16.00(-1.09%)
At close: 4:00 PM EST
¥1571.00
-¥16.00(-1.09%)
Day’s Range― - ―
52-Week Range¥1,426.00 - ¥1,785.00
Previous CloseN/A
Volume178.80K
Average Volume (3M)167.22K
Market Cap
¥118.85B
Enterprise Value¥130.30B
Total Cash (Recent Filing)¥31.13B
Total Debt (Recent Filing)¥34.56B
Price to Earnings (P/E)6.2
Beta0.46
Next Earnings
May 11, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.63%
Share Statistics
EPS (TTM)66.43
Shares Outstanding82,050,100
10 Day Avg. Volume173,620
30 Day Avg. Volume167,220
Financial Highlights & Ratios
PEG Ratio0.53
Price to Book (P/B)0.90
Price to Sales (P/S)0.47
P/FCF Ratio-23.71
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)115.9
Revenue Forecast (FY)¥285.10B
Bulls Say, Bears Say
Bulls Say
Business Model & Recurring ServicesAutobacs operates a broad AUTOBACS retail and service network that sells consumables and provides recurring maintenance and installation. Recurring demand for tires, batteries, oils and services plus bundling product sales with labor creates a stable, repeatable revenue base that supports multi-month durability and customer stickiness in the automotive aftermarket.
Revenue & Margin ImprovementReported year-over-year revenue growth and expanding gross and net margins indicate the company is improving top-line traction while capturing incremental profitability. Sustained revenue growth with margin improvement increases internal funding capacity for investment, supports operational resilience, and suggests competitive pricing or mix gains that are relevant over the next several quarters.
Conservative Leverage & Equity BaseA low debt-to-equity ratio and a strong equity ratio provide financial flexibility and lower refinancing risk. Conservative leverage allows Autobacs to fund working capital and store/network needs without excessive interest burden, improving resilience to cyclical demand swings and preserving capacity for strategic initiatives or capital allocation over the medium term.
Bears Say
Weak Cash GenerationOperating cash flow has fallen relative to reported earnings and free cash flow turned markedly negative, indicating a gap between accounting profits and cash conversion. Persistent weak cash generation constrains investment, store maintenance, and working capital funding, and increases reliance on external financing or asset sales to sustain dividend policy or growth projects.
Moderate Operating MarginsEBIT and EBITDA margins remain modest for a specialty retail and service operator, leaving limited cushion against inflation, wage pressure, or competitive pricing. Lower operating profitability restricts internal reinvestment and makes the business more sensitive to cost shocks, which can pressure cash flows and returns over multiple quarters if not improved.
Rising Debt Needs MonitoringAlthough leverage is currently conservative, a noted uptick in total debt combined with negative free cash flow raises the risk that the company may need additional financing. Increasing debt levels could reduce financial flexibility, raise interest costs, and limit capacity to invest in stores or network support over the coming months if cash generation does not recover.
Autobacs Seven Co News
9832 FAQ
What was Autobacs Seven Co Ltd’s price range in the past 12 months?
Autobacs Seven Co Ltd lowest stock price was ¥1426.00 and its highest was ¥1785.00 in the past 12 months.
What is Autobacs Seven Co Ltd’s market cap?
Autobacs Seven Co Ltd’s market cap is ¥118.85B.
When is Autobacs Seven Co Ltd’s upcoming earnings report date?
Autobacs Seven Co Ltd’s upcoming earnings report date is May 11, 2026 which is in 12 days.
How were Autobacs Seven Co Ltd’s earnings last quarter?
Autobacs Seven Co Ltd released its earnings results on Jan 30, 2026. The company reported ¥66.43 earnings per share for the quarter, beating the consensus estimate of N/A by ¥66.43.
Is Autobacs Seven Co Ltd overvalued?
According to Wall Street analysts Autobacs Seven Co Ltd’s price is currently Overvalued.
Does Autobacs Seven Co Ltd pay dividends?
Autobacs Seven Co Ltd pays a Semiannually dividend of ¥30 which represents an annual dividend yield of 3.63%. See more information on Autobacs Seven Co Ltd dividends here
What is Autobacs Seven Co Ltd’s EPS estimate?
Autobacs Seven Co Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Autobacs Seven Co Ltd have?
Autobacs Seven Co Ltd has 82,050,100 shares outstanding.
What happened to Autobacs Seven Co Ltd’s price movement after its last earnings report?
Autobacs Seven Co Ltd reported an EPS of ¥66.43 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.044%.
Which hedge fund is a major shareholder of Autobacs Seven Co Ltd?
Currently, no hedge funds are holding shares in JP:9832
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Autobacs Seven Co Ltd
Autobacs Seven Co. (9832) is a leading Japanese retailer specializing in automotive parts, accessories, and services. Founded in 1947, the company operates a chain of stores under the Autobacs brand, offering a wide range of products including tires, batteries, car audio systems, and maintenance services. In addition to retail operations, Autobacs engages in online sales and provides various automotive-related services, catering to both individual consumers and businesses in the automotive sector.
Technical Analysis
BIC Cameras
―
Yamada Denki Co
―
Autowave Co., Ltd.
―
Nojima Co Ltd
―
K'S Holdings Corporation
―
Options Prices
Currently, No data available
---